BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3609877)

  • 1. Methodology of drug trials in migraine.
    Tfelt-Hansen P; Nielsen SL
    Funct Neurol; 1986; 1(4):499-502. PubMed ID: 3609877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Controlled therapeutic trials in migraine: methodology and results].
    Baron JC; Bousser MG
    Rev Neurol (Paris); 1982; 138(4):279-95. PubMed ID: 6753081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methodology of clinical trials in migraine: a rating system].
    Tzourio C; Massiou H; Bousser MG
    Pathol Biol (Paris); 1992 Apr; 40(4):361-6. PubMed ID: 1495821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient numbers needed in prophylactic migraine trials.
    Tfelt-Hansen P; Nielsen SL
    Neuroepidemiology; 1987; 6(4):214-9. PubMed ID: 3683716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of migraine with propranolol.
    Borgesen SE
    Postgrad Med J; 1976; 52 Suppl 4():163-5. PubMed ID: 787958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodological aspects of drug trials in migraine.
    Tfelt-Hansen P; Olesen J
    Neuroepidemiology; 1985; 4(4):204-26. PubMed ID: 2872606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic treatment of migraine with tolfenamic acid. A comparative double-blind crossover study between tolfenamic acid and placebo.
    Mikkelsen BM; Falk JV
    Acta Neurol Scand; 1982 Jul; 66(1):105-11. PubMed ID: 7051739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodologic issues in acute migraine clinical trials.
    Lipton RB
    Neurology; 2000; 55(9 Suppl 2):S3-7. PubMed ID: 11089512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache.
    Haas DC; Sheehe PR
    Headache; 2004; 44(10):1029-37. PubMed ID: 15546268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies.
    Evers S; Marziniak M; Frese A; Gralow I
    Cephalalgia; 2009 Apr; 29(4):436-44. PubMed ID: 19170687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug treatment of migraine in children: state of the art].
    Cuvellier JC; Joriot S; Auvin S; Vallée L
    Arch Pediatr; 2004 May; 11(5):449-55. PubMed ID: 15135430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of botulinum toxin type A in the prophylactic treatment of migraine headaches.
    Chilson CN; Brown SJ
    Ann Pharmacother; 2005 Dec; 39(12):2081-5. PubMed ID: 16264063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.
    Honkaniemi J; Liimatainen S; Rainesalo S; Sulavuori S
    Headache; 2006 May; 46(5):781-7. PubMed ID: 16643581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol and migraine. A clinical trial.
    Pita E; Higueras A; Bolaños J; Pérez N; Mundo A
    Arch Farmacol Toxicol; 1977 Dec; 3(3):273-8. PubMed ID: 350168
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
    Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
    Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of ibuprofen-arginine in the treatment of acute migraine attacks.
    Sandrini G; Franchini S; Lanfranchi S; Granella F; Manzoni GC; Nappi G
    Int J Clin Pharmacol Res; 1998; 18(3):145-50. PubMed ID: 9825271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
    Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological aspects of prophylactic drug trials in migraine.
    Olesen J; Krabbe AA; Tfelt-Hansen P
    Cephalalgia; 1981 Sep; 1(3):127-41. PubMed ID: 7346180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.